authors
- Kavanaugh, A
- Marzo-Ortega, H
- Vender, Ronald
- Birt, J
- Adams, D
- Benichou, O
- Lin, C-Y
- Nash, P
IXEKIZUMAB IMPROVES PATIENT-REPORTED OUTCOMES THROUGH 52 WEEKS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PREVIOUS INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR-INHIBITORS
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- May 1, 2018
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- General & Internal Medicine (Science Metrix)
published in
- Internal Medicine Journal Journal